[HTML][HTML] Applications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells

P Isavand, SS Aghamiri, R Amin - Biomedicines, 2024 - mdpi.com
Given advancements in large-scale data and AI, integrating multimodal artificial intelligence
into cancer research can enhance our understanding of tumor behavior by simultaneously …

Bridging clinicopathologic features and genetics in follicular lymphoma: Towards enhanced diagnostic accuracy and subtype differentiation

J Bosch-Schips, X Parisi, F Climent, F Vega - Human Pathology, 2024 - Elsevier
Follicular lymphoma (FL) is a neoplasm that originates from germinal center B cells and
typically forms at least a partial follicular pattern. Approximately 85% of FL cases harbor the t …

Revolutionizing cancer research with spatial proteomics and visual intelligence

DF Quail, LA Walsh - nature methods, 2024 - nature.com
Spatial proteomics has transformed cancer research by providing unparalleled insights into
the microenvironmental landscape of tumors. Here we discuss how these technologies have …

Stromal Expression Profiling Reveals Immune‐Driven Adaption to Malignancy in Canine Melanoma Subtypes

E Beebe, C Krudewig, Z Motamed… - Veterinary and …, 2024 - Wiley Online Library
Canine mucosal melanoma (CMM) is the most common oral malignancy in dogs and is
significantly more aggressive than its cutaneous counterpart (CCM), yet the reasons for this …

Unraveling the role of cancer-associated fibroblasts in B cell lymphoma

P Mukherjee, SM Ansell, P Mondello - Frontiers in immunology, 2024 - frontiersin.org
Recent breakthroughs in research have sparked a paradigm shift in our understanding of
cancer biology, uncovering the critical role of the crosstalk between tumor cells and the …

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic …

MP MacManus, JF Seymour, H Tsang, R Fisher… - …, 2024 - thelancet.com
Background We report extended follow-up of TROG99. 03, a randomised phase III trial in
early-stage follicular lymphoma (ESFL) including new information on the role of adjuvant …

Follicular lymphoma research: an open dialogue for a collaborative roadmap

M Collin, G Gagey, V Shanmugam… - …, 2025 - Wiley Online Library
Follicular lymphoma (FL) is the second most common type of lymphoma (20% of all non‐
Hodgkin lymphomas), derived from germinal centre (GC) B cells, and is characterised by its …

[HTML][HTML] High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma

H Narita, K Kuroiwa, Y Kawaguchi, S Murai… - International Journal of …, 2024 - mdpi.com
Most follicular lymphomas (FLs) demonstrate an indolent clinical course with favorable
outcomes; however, a fraction of patients experiences progression of disease within 24 …

Mutational profile dynamics in follicular lymphoma and large cell transformation

EAM Hesius, WBC Stevens, JP Stewart… - Journal of Clinical …, 2025 - jcp.bmj.com
Aims Follicular lymphoma (FL) is characterised by significant heterogeneity in both the
clinical trajectories and the molecular profiles. This study aimed to investigate clonal …

High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy

J Han, CM McCall, S Isom, WM Smith… - Leukemia & …, 2024 - Taylor & Francis
Prognostic factors at diagnosis of follicular lymphoma include histology, genetic aberrations,
tumor microenvironment, prognostic indices, and tumor burden. Several clinical prognostic …